2025 Annual Results 2026.03.26 ir.wasion.com 3393.HK Disclaimer 2 ⚫ The presentation is prepared by Wasion Holdings Limited (the "Group" or the "Company" or "Wasion Holdings") and is for the purpose of corporate communication and general reference only. The presentation is not intended as an offer to sell, or to solicit an offer to buy or to form any basis of investment decision for any class of securities of the Company in any jurisdiction. All such information should not be used or relied on without profe ...

Embrace Changes for Growth Unite Strength for the Future Annual Results 2025 Table of Contents 01 Results Overview 02 Financial Review 03 Business Review 04 Outlook 05 Appendix Results Overview 01 Results Overview | (RMB mn) | 2024 | 2025 | Change | | --- | --- | --- | --- | | New car sales volume (units) | 485,307 | 497,316 | 2.5% | | Pre-owned car sales volume (units) | 226,231 | 221,213 | (2.2)% | | After-sales services visits ('000 units) | 8,048 | 8,067 | 0.2% | | Number of dealership stores | 423 | 45 ...

Group's revenue RMB 14,151 m 4.2% Mass market Professional sports RMB 12,515 m RMB 1,636 m 1.5% 30.8% Profit attributable to ordinary equity holders of the Company RMB 1,372 m 10.8% RMB 3.64 12.3% Net cash RMB 1,707 m Final dividend per Share HK 9.5 cents1 Payout ratio: 50.4% Return on equity 14.5% 0.4% pt 73.4% Xtep International Holdings Limited (Incorporated in the Cayman Islands with Limited Liability) Stock Code: 1368.HK 2025 Annual Results Presentation 26 March 2026 2025 Annual Results Highlights 4 Co ...

Better Medicines, Better Life 2025 Full-Year Earnings Conference March 2026 1 Disclaimer This presentation has been prepared by Everest Medicines Limited (the "Company" and together with its subsidiaries, the "Group") solely for information purposes and does not constitute a recommendation regarding the securities of the Group or an offer to sell or issue or the solicitation of an offer to buy or acquire securities of the Group in any jurisdiction or an inducement to enter into investment activity, nor may ...

CHINA MENGNIU DAIRY COMPANY LIMITED (2319.HK) 2025 Annual Results Legal Disclaimer The presentation is prepared by China Mengniu Dairy Company Limited (the "Company") and is provided solely for corporate communication and general reference. It is not intended to constitute an offer to sell, or to solicit an offer to buy or to form the basis of any investment decision for any class of securities of the Company in any jurisdiction. No such information should be used or relied on without professional advice. T ...

FY2025 Annual Results Presentation Advancing Pipeline 2.0 & Accelerating Global Commercialization March 27, 2026 Stock Code: 2616. HK 基石红 基石灰 白色 基石黄 基石绿 基石蓝 基石中灰 基石浅灰 基石金 品牌色 品牌辅助色 Presentation Disclaimer 基石红 基石灰 白色 基石黄 基石绿 基石蓝 基石中灰 基石浅灰 基石金 品牌色 品牌辅助色 • By attending the meeting where this presentation is made, or by reading the presentation materials, you agree to be bound by the following: • The information in this presentation has been prepared by representatives of CStone Pharmaceuticals (the "Company" a ...

Annual Results 26 March 2026 | Beijing • Hong Kong FORWARD LOOKING STATEMENT Certain statements contained in this presentation may be viewed as "forward-looking statements". These forward-looking statements state our intentions, beliefs, expectations or predictions for the future; and in some cases, we use words such as "believe", "intend", "anticipate", "estimate", "project", "forecast", "plan", "potential", "will", "may", "should" and "expect" and similar expressions to identify forward-looking statements ...

InnoCare Pharma 2025 Annual Results Earnings Call Stock Code: 09969.HK, 688428.SH March 25, 2026 1 Disclaimer These materials are for information purposes only and do not constitute or form part of an offer or invitation to sell or issue or the solicitation of an offer or invitation to buy or subscribe for securities of InnoCare Pharma Limited (the "Company") or any of its holding company or subsidiaries in any jurisdiction. No part of these materials shall form the basis of or be relied upon in connection ...

Scaled CRDMO Platform and Three Key Modalities Delivering Sustained High Growth 2025 Annual Results Operation & Business Updates 01 03 05 02 04 06 2025 Annual Results WBS (WuXi Bio Business System) & ESG as Key Components of Business Strategy FY2025 Financials Review Advanced Technology Platforms – Cornerstone of Future Success Summary & Outlook 01 2025 Annual Results March 2026 Stock Code: 2269.HK Forward-Looking Statements This presentation may contain certain "forward-looking statements" which are not hi ...

Disclaimer DPC Dash Ltd (1405.HK) 2025 Full Year Results Presentation March 25, 2026 This presentation has been prepared by DPC Dash Ltd (the "Company" and together with its subsidiaries, the "Group") solely for information purposes and does not constitute a recommendation regarding the securities of the Group or an offer to sell or issue or the solicitation of an offer to buy or acquire securities of the Group in any jurisdiction or an inducement to enter into investment activity, nor may it or any part of ...